{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:21:51Z","timestamp":1792074111595,"version":"4.4.0"},"reference-count":79,"publisher":"The Microbiological Society of Korea","issue":"3","license":[{"start":{"date-parts":[[2016,2,27]],"date-time":"2016-02-27T00:00:00Z","timestamp":1456531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Microbiol."],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s12275-016-5628-4","type":"journal-article","created":{"date-parts":[[2016,2,26]],"date-time":"2016-02-26T06:12:03Z","timestamp":1456467123000},"page":"192-201","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":102,"title":["The development of fluconazole resistance in Candida albicans \u2013 an example of microevolution of a fungal pathogen"],"prefix":"10.71150","volume":"54","author":[{"given":"Joachim","family":"Morschh\u00e4user","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4586","published-online":{"date-parts":[[2016,2,27]]},"reference":[{"key":"5628_CR1","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1128\/JB.181.3.700-708.1999","volume":"181","author":"A.M. Alarco","year":"1999","unstructured":"Alarco, A.M. and Raymond, M. 1999. The bZip transcription factor Cap1p is involved in multidrug resistance and oxidative stress response in Candida albicans. J. Bacteriol. 181, 700\u2013708.","journal-title":"J. Bacteriol."},{"key":"5628_CR2","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1091\/mbc.E09-01-0040","volume":"20","author":"K. Alby","year":"2009","unstructured":"Alby, K. and Bennett, R.J. 2009. Stress-induced phenotypic switching in Candida albicans. Mol. Biol. Cell. 20, 3178\u20133191.","journal-title":"Mol. Biol. Cell."},{"key":"5628_CR3","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1128\/AAC.01053-05","volume":"50","author":"D. Andes","year":"2006","unstructured":"Andes, D., Forrest, A., Lepak, A., Nett, J., Marchillo, K., and Lincoln, L. 2006. Impact of antimicrobial dosing regimen on evolution of drug resistance in vivo: fluconazole and Candida albicans. Antimicrob. Agents Chemother. 50, 2374\u20132383.","journal-title":"Antimicrob. Agents Chemother."},{"key":"5628_CR4","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1128\/AAC.01223-07","volume":"52","author":"L. Angiolella","year":"2008","unstructured":"Angiolella, L., Stringaro, A.R., De Bernardis, F., Posteraro, B., Bonito, M., Toccacieli, L., Torosantucci, A., Colone, M., Sanguinetti, M., Cassone, A., et al. 2008. Increase of virulence and its phenotypic traits in drug-resistant strains of Candida albicans. Antimicrob. Agents Chemother. 52, 927\u2013936.","journal-title":"Antimicrob. Agents Chemother."},{"key":"5628_CR5","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1128\/AAC.43.5.1163","volume":"43","author":"K. Asai","year":"1999","unstructured":"Asai, K., Tsuchimori, N., Okonogi, K., Perfect, J.R., Gotoh, O., and Yoshida, Y. 1999. Formation of azole-resistant Candida albicans by mutation of sterol 14-demethylase P450. Antimicrob. Agents Chemother. 43, 1163\u20131169.","journal-title":"Antimicrob. Agents Chemother."},{"key":"5628_CR6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.tig.2012.01.004","volume":"28","author":"J. Berman","year":"2012","unstructured":"Berman, J. and Hadany, L. 2012. Does stress induce (para)sex? Implications for Candida albicans evolution. Trends Genet. 28, 197\u2013203.","journal-title":"Trends Genet."},{"key":"5628_CR7","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1128\/AAC.41.3.535","volume":"41","author":"H.M. Calvet","year":"1997","unstructured":"Calvet, H.M., Yeaman, M.R., and Filler, S.G. 1997. Reversible fluconazole resistance in Candida albicans: a potential in vitro model. Antimicrob. Agents Chemother. 41, 535\u2013539.","journal-title":"Antimicrob. Agents Chemother."},{"key":"5628_CR8","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1128\/AAC.49.9.3646-3651.2005","volume":"49","author":"A.S. Chau","year":"2005","unstructured":"Chau, A.S., Gurnani, M., Hawkinson, R., Laverdiere, M., Cacciapuoti, A., and McNicholas, P.M. 2005. Inactivation of sterol \u03945,6-desaturase attenuates virulence in Candida albicans. Antimicrob. Agents Chemother. 49, 3646\u20133651.","journal-title":"Antimicrob. Agents Chemother."},{"key":"5628_CR9","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1128\/EC.00151-07","volume":"6","author":"A. Coste","year":"2007","unstructured":"Coste, A., Selmecki, A., Forche, A., Diogo, D., Bougnoux, M.E., d\u2019Enfert, C., Berman, J., and Sanglard, D. 2007. Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates. Eukaryot. Cell 6, 1889\u20131904.","journal-title":"Eukaryot. Cell"},{"key":"5628_CR10","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1534\/genetics.105.054767","volume":"172","author":"A. Coste","year":"2006","unstructured":"Coste, A., Turner, V., Ischer, F., Morschh\u00e4user, J., Forche, A., Selmecki, A., Berman, J., Bille, J., and Sanglard, D. 2006. A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans. Genetics 172, 2139\u20132156.","journal-title":"Genetics"},{"key":"5628_CR11","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1128\/EC.00069-09","volume":"8","author":"A.T. Coste","year":"2009","unstructured":"Coste, A.T., Crittin, J., Bauser, C., Rohde, B., and Sanglard, D. 2009. Functional analysis of cis- and trans-acting elements of the Candida albicans CDR2 promoter with a novel promoter reporter system. Eukaryot. Cell 8, 1250\u20131267.","journal-title":"Eukaryot. Cell"},{"key":"5628_CR12","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1128\/EC.3.6.1639-1652.2004","volume":"3","author":"A.T. Coste","year":"2004","unstructured":"Coste, A.T., Karababa, M., Ischer, F., Bille, J., and Sanglard, D. 2004. TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2. Eukaryot. Cell 3, 1639\u20131652.","journal-title":"Eukaryot. Cell"},{"key":"5628_CR13","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/emboj\/21.4.546","volume":"21","author":"M.C. Cruz","year":"2002","unstructured":"Cruz, M.C., Goldstein, A.L., Blankenship, J.R., Del Poeta, M., Davis, D., Cardenas, M.E., Perfect, J.R., McCusker, J.H., and Heitman, J. 2002. Calcineurin is essential for survival during membrane stress in Candida albicans. EMBO J. 21, 546\u2013559.","journal-title":"EMBO J."},{"key":"5628_CR14","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1365-2958.2008.06309.x","volume":"69","author":"N. B. J. Dunkel","year":"2008","unstructured":"Dunkel, N., Bla\u03b2, J., Rogers, P.D., and Morschh\u00e4user, J. 2008a. Mutations in the multi-drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole-resistant Candida albicans strains. Mol. Microbiol. 69, 827\u2013840.","journal-title":"Mol. Microbiol."},{"key":"5628_CR15","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1128\/EC.00103-08","volume":"7","author":"N. Dunkel","year":"2008","unstructured":"Dunkel, N., Liu, T.T., Barker, K.S., Homayouni, R., Morschh\u00e4user, J., and Rogers, P.D. 2008b. A gain-of-function mutation in the transcription factor Upc2p causes upregulation of ergosterol biosynthesis genes and increased fluconazole resistance in a clinical Candida albicans isolate. Eukaryot. Cell 7, 1180\u20131190.","journal-title":"Eukaryot. Cell"},{"key":"5628_CR16","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1099\/00221287-145-10-2715","volume":"145","author":"B. Favre","year":"1999","unstructured":"Favre, B., Didmon, M., and Ryder, N.S. 1999. Multiple amino acid substitutions in lanosterol 14a-demethylase contribute to azole resistance in Candida albicans. Microbiology 145, 2715\u20132725.","journal-title":"Microbiology"},{"key":"5628_CR17","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1128\/EC.00215-12","volume":"11","author":"S.A. Flowers","year":"2012","unstructured":"Flowers, S.A., Barker, K.S., Berkow, E.L., Toner, G., Chadwick, S.G., Gygax, S.E., Morschh\u00e4user, J., and Rogers, P.D. 2012. Gain-offunction mutations in UPC2 are a frequent cause of ERG11 upregulation in azole-resistant clinical isolates of Candida albicans. Eukaryot. Cell 11, 1289\u20131299.","journal-title":"Eukaryot. Cell"},{"key":"5628_CR18","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/AAC.03470-14","volume":"59","author":"S.A. Flowers","year":"2015","unstructured":"Flowers, S.A., Colon, B., Whaley, S.G., Schuler, M.A., and Rogers, P.D. 2015. Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicans. Antimicrob. Agents Chemother. 59, 450\u2013460.","journal-title":"Antimicrob. Agents Chemother."},{"key":"5628_CR19","doi-asserted-by":"crossref","first-page":"e00129","DOI":"10.1128\/mBio.00129-11","volume":"2","author":"A. Forche","year":"2011","unstructured":"Forche, A., Abbey, D., Pisithkul, T., Weinzierl, M.A., Ringstrom, T., Bruck, D., Petersen, K., and Berman, J. 2011. Stress alters rates and types of loss of heterozygosity in Candida albicans. mBio 2, e00129\u201311.","journal-title":"mBio"},{"key":"5628_CR20","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1371\/journal.pbio.0060110","volume":"6","author":"A. Forche","year":"2008","unstructured":"Forche, A., Alby, K., Schaefer, D., Johnson, A.D., Berman, J., and Bennett, R.J. 2008. The parasexual cycle in Candida albicans provides an alternative pathway to meiosis for the formation of recombinant strains. PLoS Biol. 6, e110.","journal-title":"PLoS Biol."},{"key":"5628_CR21","doi-asserted-by":"crossref","first-page":"e00662","DOI":"10.7554\/eLife.00662","volume":"4","author":"C.B. Ford","year":"2015","unstructured":"Ford, C.B., Funt, J.M., Abbey, D., Issi, L., Guiducci, C., Martinez, D.A., Delorey, T., Li, B.Y., White, T.C., Cuomo, C., et al. 2015. The evolution of drug resistance in clinical isolates of Candida albicans. Elife 4, e00662.","journal-title":"Elife"},{"key":"5628_CR22","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1128\/AAC.42.12.3065","volume":"42","author":"R. Franz","year":"1998","unstructured":"Franz, R., Kelly, S.L., Lamb, D.C., Kelly, D.E., Ruhnke, M., and Morschh\u00e4user, J. 1998. Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains. Antimicrob. Agents Chemother. 42, 3065\u20133072.","journal-title":"Antimicrob. Agents Chemother."},{"key":"5628_CR23","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1439-0507.1999.00498.x","volume":"42","author":"R. Franz","year":"1999","unstructured":"Franz, R., Ruhnke, M., and Morschh\u00e4user, J. 1999. Molecular aspects of fluconazole resistance development in Candida albicans. Mycoses 42, 453\u2013458.","journal-title":"Mycoses"},{"key":"5628_CR24","doi-asserted-by":"crossref","first-page":"e1001815","DOI":"10.1371\/journal.pbio.1001815","volume":"12","author":"B.D. Harrison","year":"2014","unstructured":"Harrison, B.D., Hashemi, J., Bibi, M., Pulver, R., Bavli, D., Nahmias, Y., Wellington, M., Sapiro, G., and Berman, J. 2014. A tetraploid intermediate precedes aneuploid formation in yeasts exposed to fluconazole. PLoS Biol. 12, e1001815.","journal-title":"PLoS Biol."},{"key":"5628_CR25","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1574-6968.2011.02490.x","volume":"328","author":"K. Hayama","year":"2012","unstructured":"Hayama, K., Ishibashi, H., Ishijima, S.A., Niimi, K., Tansho, S., Ono, Y., Monk, B.C., Holmes, A.R., Harding, D.R., Cannon, R.D., et al. 2012. A D-octapeptide drug efflux pump inhibitor acts synergistically with azoles in a murine oral candidiasis infection model. FEMS Microbiol. Lett. 328, 130\u2013137.","journal-title":"FEMS Microbiol. Lett."},{"key":"5628_CR26","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1128\/AAC.01102-09","volume":"54","author":"C.J. Heilmann","year":"2010","unstructured":"Heilmann, C.J., Schneider, S., Barker, K.S., Rogers, P.D., and Morschh\u00e4user, J. 2010. An A643T mutation in the transcription factor Upc2p causes constitutive ERG11 upregulation and increased fluconazole resistance in Candida albicans. Antimicrob. Agents Chemother. 54, 353\u2013359.","journal-title":"Antimicrob. Agents Chemother."},{"key":"5628_CR27","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1128\/AAC.00995-10","volume":"55","author":"S.J. Hoot","year":"2011","unstructured":"Hoot, S.J., Smith, A.R., Brown, R.P., and White, T.C. 2011. An A643V amino acid substitution in Upc2p contributes to azole resistance in well-characterized clinical isolates of Candida albicans. Antimicrob. Agents Chemother. 55, 940\u2013942.","journal-title":"Antimicrob. Agents Chemother."},{"key":"5628_CR28","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.cub.2009.01.018","volume":"19","author":"G. Huang","year":"2009","unstructured":"Huang, G., Srikantha, T., Sahni, N., Yi, S., and Soll, D.R. 2009. CO2 regulates white-to-opaque switching in Candida albicans. Curr. Biol. 19, 330\u2013334.","journal-title":"Curr. Biol."},{"key":"5628_CR29","doi-asserted-by":"crossref","first-page":"e1000806","DOI":"10.1371\/journal.ppat.1000806","volume":"6","author":"G. Huang","year":"2010","unstructured":"Huang, G., Yi, S., Sahni, N., Daniels, K.J., Srikantha, T., and Soll, D.R. 2010. N-acetylglucosamine induces white to opaque switching, a mating prerequisite in Candida albicans. PLoS Pathog. 6, e1000806.","journal-title":"PLoS Pathog."},{"key":"5628_CR30","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1128\/EC.05168-11","volume":"10","author":"M. Huang","year":"2011","unstructured":"Huang, M., McClellan, M., Berman, J., and Kao, K.C. 2011. Evolutionary dynamics of Candida albicans during in vitro evolution. Eukaryot. Cell 10, 1413\u20131421.","journal-title":"Eukaryot. Cell"},{"key":"5628_CR31","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1128\/AAC.47.10.3195-3201.2003","volume":"47","author":"P. Jain","year":"2003","unstructured":"Jain, P., Akula, I., and Edlind, T. 2003. Cyclic AMP signaling pathway modulates susceptibility of Candida species and Saccharomyces cerevisiae to antifungal azoles and other sterol biosynthesis inhibitors. Antimicrob. Agents Chemother. 47, 3195\u20133201.","journal-title":"Antimicrob. Agents Chemother."},{"key":"5628_CR32","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1128\/AAC.44.11.2985-2990.2000","volume":"44","author":"H. Kakeya","year":"2000","unstructured":"Kakeya, H., Miyazaki, Y., Miyazaki, H., Nyswaner, K., Grimberg, B., and Bennett, J.E. 2000. Genetic analysis of azole resistance in the Darlington strain of Candida albicans. Antimicrob. Agents Chemother. 44, 2985\u20132990.","journal-title":"Antimicrob. Agents Chemother."},{"key":"5628_CR33","first-page":"171","volume":"180","author":"S.L. Kelly","year":"1999","unstructured":"Kelly, S.L., Lamb, D.C., and Kelly, D.E. 1999a. Y132H substitution in Candida albicans sterol 14a-demethylase confers fluconazole resistance by preventing binding to haem. FEMS Microbiol. Lett. 180, 171\u2013175.","journal-title":"FEMS Microbiol. Lett."},{"key":"5628_CR34","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0014-5793(96)01360-9","volume":"400","author":"S.L. Kelly","year":"1997","unstructured":"Kelly, S.L., Lamb, D.C., Kelly, D.E., Manning, N.J., Loeffler, J., Hebart, H., Schumacher, U., and Einsele, H. 1997. Resistance to fluconazole and cross-resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol \u03945,6-desaturation. FEBS Lett. 400, 80\u201382.","journal-title":"FEBS Lett."},{"key":"5628_CR35","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1006\/bbrc.1999.1136","volume":"262","author":"S.L. Kelly","year":"1999","unstructured":"Kelly, S.L., Lamb, D.C., Loeffler, J., Einsele, H., and Kelly, D.E. 1999b. The G464S amino acid substitution in Candida albicans sterol 14a-demethylase causes fluconazole resistance in the clinic through reduced affinity. Biochem. Biophys. Res. Commun. 262, 174\u2013179.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"5628_CR36","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s00438-004-0984-x","volume":"271","author":"H. Kusch","year":"2004","unstructured":"Kusch, H., Biswas, K., Schwanfelder, S., Engelmann, S., Rogers, P.D., Hecker, M., and Morschh\u00e4user, J. 2004. A proteomic approach to understanding the development of multidrug-resistant Candida albicans strains. Mol. Genet. Genomics 271, 554\u2013565.","journal-title":"Mol. Genet. Genomics"},{"key":"5628_CR37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1128\/AAC.44.1.63-67.2000","volume":"44","author":"D.C. Lamb","year":"2000","unstructured":"Lamb, D.C., Kelly, D.E., White, T.C., and Kelly, S.L. 2000. The R467K amino acid substitution in Candida albicans sterol 14a- demethylase causes drug resistance through reduced affinity. Antimicrob. Agents Chemother. 44, 63\u201367.","journal-title":"Antimicrob. Agents Chemother."},{"key":"5628_CR38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1128\/EC.00245-13","volume":"13","author":"A. Lohberger","year":"2014","unstructured":"Lohberger, A., Coste, A.T., and Sanglard, D. 2014. Distinct roles of Candida albicans drug resistance transcription factors TAC1, MRR1, and UPC2 in virulence. Eukaryot. Cell 13, 127\u2013142.","journal-title":"Eukaryot. Cell"},{"key":"5628_CR39","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1128\/AAC.49.5.1745-1752.2005","volume":"49","author":"S. MacPherson","year":"2005","unstructured":"MacPherson, S., Akache, B., Weber, S., De Deken, X., Raymond, M., and Turcotte, B. 2005. Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes. Antimicrob. Agents Chemother. 49, 1745\u20131752.","journal-title":"Antimicrob. Agents Chemother."},{"key":"5628_CR40","doi-asserted-by":"crossref","first-page":"e1001126","DOI":"10.1371\/journal.ppat.1001126","volume":"6","author":"B.E. Mansfield","year":"2010","unstructured":"Mansfield, B.E., Oltean, H.N., Oliver, B.G., Hoot, S.J., Leyde, S.E., Hedstrom, L., and White, T.C. 2010. Azole drugs are imported by facilitated diffusion in Candida albicans and other pathogenic fungi. PLoS Pathog. 6, e1001126.","journal-title":"PLoS Pathog."},{"key":"5628_CR41","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/AAC.45.1.52-59.2001","volume":"45","author":"K.A. Marr","year":"2001","unstructured":"Marr, K.A., Lyons, C.N., Ha, K., Rustad, T.R., and White, T.C. 2001. Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans. Antimicrob. Agents Chemother. 45, 52\u201359.","journal-title":"Antimicrob. Agents Chemother."},{"key":"5628_CR42","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1128\/AAC.42.10.2584","volume":"42","author":"K.A. Marr","year":"1998","unstructured":"Marr, K.A., Lyons, C.N., Rustad, T.R., Bowden, R.A., and White, T.C. 1998. Rapid, transient fluconazole resistance in Candida albicans is associated with increased mRNA levels of CDR. Antimicrob. Agents Chemother. 42, 2584\u20132589.","journal-title":"Antimicrob. Agents Chemother."},{"key":"5628_CR43","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1128\/AAC.00348-10","volume":"54","author":"C.M. Martel","year":"2010","unstructured":"Martel, C.M., Parker, J.E., Bader, O., Weig, M., Gross, U., Warrilow, A.G., Rolley, N., Kelly, D.E., and Kelly, S.L. 2010. Identification and characterization of four azole-resistant erg3 mutants of Candida albicans. Antimicrob. Agents Chemother. 54, 4527\u20134533.","journal-title":"Antimicrob. Agents Chemother."},{"key":"5628_CR44","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/jac\/49.3.515","volume":"49","author":"M. Martinez","year":"2002","unstructured":"Martinez, M., Lopez-Ribot, J.L., Kirkpatrick, W.R., Bachmann, S.P., Perea, S., Ruesga, M.T., and Patterson, T.F. 2002. Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis. J. Antimicrob. Chemother. 49, 515\u2013524.","journal-title":"J. Antimicrob. Chemother."},{"key":"5628_CR45","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0092-8674(02)00837-1","volume":"110","author":"M.G. Miller","year":"2002","unstructured":"Miller, M.G. and Johnson, A.D. 2002. White-opaque switching in Candida albicans is controlled by mating-type locus homeodomain proteins and allows efficient mating. Cell 110, 293\u2013302.","journal-title":"Cell"},{"key":"5628_CR46","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1128\/AAC.50.2.580-586.2006","volume":"50","author":"T. Miyazaki","year":"2006","unstructured":"Miyazaki, T., Miyazaki, Y., Izumikawa, K., Kakeya, H., Miyakoshi, S., Bennett, J.E., and Kohno, S. 2006. Fluconazole treatment is effective against a Candida albicans erg3\/erg3 mutant in vivo despite in vitro resistance. Antimicrob. Agents Chemother. 50, 580\u2013586.","journal-title":"Antimicrob. Agents Chemother."},{"key":"5628_CR47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0378-1119(99)00263-2","volume":"236","author":"Y. Miyazaki","year":"1999","unstructured":"Miyazaki, Y., Geber, A., Miyazaki, H., Falconer, D., Parkinson, T., Hitchcock, C., Grimberg, B., Nyswaner, K., and Bennett, J.E. 1999. Cloning, sequencing, expression and allelic sequence diversity of ERG3 (C-5 sterol desaturase gene) in Candida albicans. Gene 236, 43\u201351.","journal-title":"Gene"},{"key":"5628_CR48","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/jac\/dks186","volume":"67","author":"F. Morio","year":"2012","unstructured":"Morio, F., Pagniez, F., Lacroix, C., Miegeville, M., and Le Pape, P. 2012. Amino acid substitutions in the Candida albicans sterol \u03945,6-desaturase (Erg3p) confer azole resistance: characterization of two novel mutants with impaired virulence. J. Antimicrob. Chemother. 67, 2131\u20132138.","journal-title":"J. Antimicrob. Chemother."},{"key":"5628_CR49","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1371\/journal.ppat.0030164","volume":"3","author":"J. Morschh\u00e4user","year":"2007","unstructured":"Morschh\u00e4user, J., Barker, K.S., Liu, T.T., Bla\u03b2- Warmuth, J., Homayouni, R., and Rogers, P.D. 2007. The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans. PLoS Pathog. 3, e164.","journal-title":"PLoS Pathog."},{"key":"5628_CR50","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1365-2958.1999.01393.x","volume":"32","author":"J. Morschh\u00e4user","year":"1999","unstructured":"Morschh\u00e4user, J., Michel, S., and Staib, P. 1999. Sequential gene disruption in Candida albicans by FLP-mediated site-specific recombination. Mol. Microbiol. 32, 547\u2013556.","journal-title":"Mol. Microbiol."},{"key":"5628_CR51","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1128\/AAC.45.10.2676-2684.2001","volume":"45","author":"S. Perea","year":"2001","unstructured":"Perea, S., Lopez-Ribot, J.L., Kirkpatrick, W.R., McAtee, R.K., Santillan, R.A., Martinez, M., Calabrese, D., Sanglard, D., and Patterson, T.F. 2001. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother. 45, 2676\u20132684.","journal-title":"Antimicrob. Agents Chemother."},{"key":"5628_CR52","doi-asserted-by":"crossref","first-page":"e1000089","DOI":"10.1371\/journal.ppat.1000089","volume":"4","author":"B. Ram\u00edrez-Zavala","year":"2008","unstructured":"Ram\u00edrez-Zavala, B., Reu\u03b2, O., Park, Y.N., Ohlsen, K., and Morschh\u00e4user, J. 2008. Environmental induction of white-opaque switching in Candida albicans. PLoS Pathog. 4, e1000089.","journal-title":"PLoS Pathog."},{"key":"5628_CR53","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1099\/00221287-148-4-1061","volume":"148","author":"T.R. Rustad","year":"2002","unstructured":"Rustad, T.R., Stevens, D.A., Pfaller, M.A., and White, T.C. 2002. Homozygosity at the Candida albicans MTL locus associated with azole resistance. Microbiology 148, 1061\u20131072.","journal-title":"Microbiology"},{"key":"5628_CR54","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1111\/j.1365-2958.2006.05196.x","volume":"60","author":"S. Saidane","year":"2006","unstructured":"Saidane, S., Weber, S., De Deken, X., St-Germain, G., and Raymond, M. 2006. PDR16-mediated azole resistance in Candida albicans. Mol. Microbiol. 60, 1546\u20131562.","journal-title":"Mol. Microbiol."},{"key":"5628_CR55","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/jac\/42.2.241","volume":"42","author":"D. Sanglard","year":"1998","unstructured":"Sanglard, D., Ischer, F., Koymans, L., and Bille, J. 1998. Amino acid substitutions in the cytochrome P-450 lanosterol 14a-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents. Antimicrob. Agents Chemother. 42, 241\u2013253.","journal-title":"Antimicrob. Agents Chemother."},{"key":"5628_CR56","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1046\/j.1365-2958.2003.03495.x","volume":"48","author":"D. Sanglard","year":"2003","unstructured":"Sanglard, D., Ischer, F., Marchetti, O., Entenza, J., and Bille, J. 2003a. Calcineurin A of Candida albicans: involvement in antifungal tolerance, cell morphogenesis and virulence. Mol. Microbiol. 48, 959\u2013976.","journal-title":"Mol. Microbiol."},{"key":"5628_CR57","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1128\/AAC.40.10.2300","volume":"40","author":"D. Sanglard","year":"1996","unstructured":"Sanglard, D., Ischer, F., Monod, M., and Bille, J. 1996. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob. Agents Chemother. 40, 2300\u20132305.","journal-title":"Antimicrob. Agents Chemother."},{"key":"5628_CR58","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1099\/00221287-143-2-405","volume":"143","author":"D. Sanglard","year":"1997","unstructured":"Sanglard, D., Ischer, F., Monod, M., and Bille, J. 1997. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. Microbiology 143, 405\u2013416.","journal-title":"Microbiology"},{"key":"5628_CR59","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1128\/AAC.47.8.2404-2412.2003","volume":"47","author":"D. Sanglard","year":"2003","unstructured":"Sanglard, D., Ischer, F., Parkinson, T., Falconer, D., and Bille, J. 2003b. Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents. Antimicrob. Agents Chemother. 47, 2404\u20132412.","journal-title":"Antimicrob. Agents Chemother."},{"key":"5628_CR60","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1128\/AAC.39.11.2378","volume":"39","author":"D. Sanglard","year":"1995","unstructured":"Sanglard, D., Kuchler, K., Ischer, F., Pagani, J.L., Monod, M., and Bille, J. 1995. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39, 2378\u20132386.","journal-title":"Antimicrob. Agents Chemother."},{"key":"5628_CR61","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2958.2012.08210.x","volume":"86","author":"C. Sasse","year":"2012","unstructured":"Sasse, C., Dunkel, N., Sch\u00e4fer, T., Schneider, S., Dierolf, F., Ohlsen, K., and Morschh\u00e4user, J. 2012. The stepwise acquisition of fluconazole resistance mutations causes a gradual loss of fitness in Candida albicans. Mol. Microbiol. 86, 539\u2013556.","journal-title":"Mol. Microbiol."},{"key":"5628_CR62","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/mmi.12327","volume":"89","author":"R. Schillig","year":"2013","unstructured":"Schillig, R. and Morschh\u00e4user, J. 2013. Analysis of a fungus-specific transcription factor family, the Candida albicans zinc cluster proteins, by artificial activation. Mol. Microbiol. 89, 1003\u20131017.","journal-title":"Mol. Microbiol."},{"key":"5628_CR63","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1128\/AAC.01343-10","volume":"55","author":"S. Schubert","year":"2011","unstructured":"Schubert, S., Barker, K.S., Znaidi, S., Schneider, S., Dierolf, F., Dunkel, N., Aid, M., Boucher, G., Rogers, P.D., Raymond, M., et al. 2011. Regulation of efflux pump expression and drug resistance by the transcription factors Mrr1, Upc2, and Cap1 in Candida albicans. Antimicrob. Agents Chemother. 55, 2212\u20132223.","journal-title":"Antimicrob. Agents Chemother."},{"key":"5628_CR64","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1128\/AAC.00740-08","volume":"52","author":"S. Schubert","year":"2008","unstructured":"Schubert, S., Rogers, P.D., and Morschh\u00e4user, J. 2008. Gain-offunction mutations in the transcription factor MRR1 are responsible for overexpression of the MDR1 efflux pump in fluconazole- resistant Candida dubliniensis strains. Antimicrob. Agents Chemother. 52, 4274\u20134280.","journal-title":"Antimicrob. Agents Chemother."},{"key":"5628_CR65","doi-asserted-by":"crossref","first-page":"e522530","DOI":"10.1111\/j.1439-0507.2010.01970.x","volume":"54","author":"B. Schulz","year":"2011","unstructured":"Schulz, B., Weber, K., Schmidt, A., Borg-von Zepelin, M., and Ruhnke, M. 2011. Difference in virulence between fluconazole- susceptible and fluconazole-resistant Candida albicans in a mouse model. Mycoses 54, e522530.","journal-title":"Mycoses"},{"key":"5628_CR66","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1126\/science.1128242","volume":"313","author":"A. Selmecki","year":"2006","unstructured":"Selmecki, A., Forche, A., and Berman, J. 2006. Aneuploidy and isochromosome formation in drug-resistant Candida albicans. Science 313, 367\u2013370.","journal-title":"Science"},{"key":"5628_CR67","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1365-2958.2008.06176.x","volume":"68","author":"A. Selmecki","year":"2008","unstructured":"Selmecki, A., Gerami-Nejad, M., Paulson, C., Forche, A., and Berman, J. 2008. An isochromosome confers drug resistance in vivo by amplification of two genes, ERG11 and TAC1. Mol. Microbiol. 68, 624\u2013641.","journal-title":"Mol. Microbiol."},{"key":"5628_CR68","doi-asserted-by":"crossref","first-page":"e1000705","DOI":"10.1371\/journal.pgen.1000705","volume":"5","author":"A.M. Selmecki","year":"2009","unstructured":"Selmecki, A.M., Dulmage, K., Cowen, L.E., Anderson, J.B., and Berman, J. 2009. Acquisition of aneuploidy provides increased fitness during the evolution of antifungal drug resistance. PLoS Genet. 5, e1000705.","journal-title":"PLoS Genet."},{"key":"5628_CR69","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1128\/EC.3.6.1391-1397.2004","volume":"3","author":"P.M. Silver","year":"2004","unstructured":"Silver, P.M., Oliver, B.G., and White, T.C. 2004. Role of Candida albicans transcription factor Upc2p in drug resistance and sterol metabolism. Eukaryot. Cell 3, 1391\u20131397.","journal-title":"Eukaryot. Cell"},{"key":"5628_CR70","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1128\/JB.181.1.231-240.1999","volume":"181","author":"D. Talibi","year":"1999","unstructured":"Talibi, D. and Raymond, M. 1999. Isolation of a putative Candida albicans transcriptional regulator involved in pleiotropic drug resistance by functional complementation of a pdr1 pdr3 mutation in Saccharomyces cerevisiae. J. Bacteriol. 181, 231\u2013240.","journal-title":"J. Bacteriol."},{"key":"5628_CR71","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1128\/AAC.00926-08","volume":"53","author":"S. Tsao","year":"2009","unstructured":"Tsao, S., Rahkhoodaee, F., and Raymond, M. 2009. Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance. Antimicrob. Agents Chemother. 53, 1344\u20131352.","journal-title":"Antimicrob. Agents Chemother."},{"key":"5628_CR72","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1128\/AAC.05720-11","volume":"56","author":"L.A. Vale-Silva","year":"2012","unstructured":"Vale-Silva, L.A., Coste, A.T., Ischer, F., Parker, J.E., Kelly, S.L., Pinto, E., and Sanglard, D. 2012. Azole resistance by loss of function of the sterol \u03945,6-desaturase gene (ERG3) in Candida albicans does not necessarily decrease virulence. Antimicrob. Agents Chemother. 56, 1960\u20131968.","journal-title":"Antimicrob. Agents Chemother."},{"key":"5628_CR73","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ijantimicag.2015.08.001","volume":"46","author":"Y. Wang","year":"2015","unstructured":"Wang, Y., Liu, J.Y., Shi, C., Li, W.J., Zhao, Y., Yan, L., and Xiang, M.J. 2015. Mutations in transcription factor Mrr2p contribute to fluconazole resistance in clinical isolates of Candida albicans. Int. J. Antimicrob. Agents 46, 552\u2013559.","journal-title":"Int. J. Antimicrob. Agents"},{"key":"5628_CR74","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1128\/AAC.41.7.1482","volume":"41","author":"T.C. White","year":"1997","unstructured":"White, T.C. 1997a. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 41, 1482\u20131487.","journal-title":"Antimicrob. Agents Chemother."},{"key":"5628_CR75","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1128\/AAC.41.7.1488","volume":"41","author":"T.C. White","year":"1997","unstructured":"White, T.C. 1997b. The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14a demethylase in Candida albicans. Antimicrob. Agents Chemother. 41, 1488\u20131494.","journal-title":"Antimicrob. Agents Chemother."},{"key":"5628_CR76","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/CMR.11.2.382","volume":"11","author":"T.C. White","year":"1998","unstructured":"White, T.C., Marr, K.A., and Bowden, R.A. 1998. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin. Microbiol. Rev. 11, 382\u2013402.","journal-title":"Clin. Microbiol. Rev."},{"key":"5628_CR77","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1046\/j.1365-2958.2000.01899.x","volume":"36","author":"S. Wirsching","year":"2000","unstructured":"Wirsching, S., Michel, S., and Morschh\u00e4user, J. 2000. Targeted gene disruption in Candida albicans wild-type strains: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates. Mol. Microbiol. 36, 856\u2013865.","journal-title":"Mol. Microbiol."},{"key":"5628_CR78","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1365-2958.2007.05931.x","volume":"66","author":"S. D. Znaidi","year":"2007","unstructured":"Znaidi, S., De Deken, X., Weber, S., Rigby, T., Nantel, A., and Raymond, M. 2007. The zinc cluster transcription factor Tac1p regulates PDR16 expression in Candida albicans. Mol. Microbiol. 66, 440\u2013452.","journal-title":"Mol. Microbiol."},{"key":"5628_CR79","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1128\/EC.00070-08","volume":"7","author":"S. Znaidi","year":"2008","unstructured":"Znaidi, S., Weber, S., Al-Abdin, O.Z., Bomme, P., Saidane, S., Drouin, S., Lemieux, S., De Deken, X., Robert, F., and Raymond, M. 2008. Genomewide location analysis of Candida albicans Upc2p, a regulator of sterol metabolism and azole drug resistance. Eukaryot. Cell 7, 836\u2013847.","journal-title":"Eukaryot. Cell"}],"container-title":["Journal of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12275-016-5628-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12275-016-5628-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12275-016-5628-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T17:47:19Z","timestamp":1735062439000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12275-016-5628-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,27]]},"references-count":79,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["5628"],"URL":"https:\/\/doi.org\/10.1007\/s12275-016-5628-4","relation":{},"ISSN":["1225-8873","1976-3794"],"issn-type":[{"value":"1225-8873","type":"print"},{"value":"1976-3794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,27]]}}}